top of page


Onco-Summaries: Daily Oncology Updates at a Glance
04/07/2025 Imfinzi has been approved by the EC as a perioperative immunotherapy for muscle-invasive bladder cancer ( Ref ) AstraZeneca’s...
Oncofocus Team
Jul 7, 20251 min read


Onco-Summaries: Daily Oncology Updates at a Glance
02/07/2025 Lynozyfic received accelerated approval from the US FDA for R/R Multiple Myeloma ( Ref ) Regeneron Pharmaceuticals announced...
Oncofocus Team
Jul 3, 20252 min read


Onco-Summaries: Daily Oncology Updates at a Glance
01/07/2025 HanchorBio and Henlius signed a ~$200M licensing deal for HanchorBio's HCB101 ( Ref ) HanchorBio and Shanghai Henlius Biotech...
Oncofocus Team
Jul 2, 20252 min read


AbbVie is set to acquire University of Pennsylvania’s spinout, Capstan Therapeutics
📢 AbbVie is set to acquire University of Pennsylvania ’s spinout, Capstan Therapeutics for up to $2.1 billion in cash, representing...
Oncofocus Team
Jul 2, 20251 min read


Onco-Summaries: Daily Oncology Updates at a Glance
30/06/2025 Revolution Medicines and Summit entered into a clinical collaboration to evaluate RAS(ON) inhibitors and ivonescimab...
Oncofocus Team
Jul 1, 20252 min read


Oncology Updates - Key Oncology News
June 4th Week,2025 Regulatory Events 🎯 Daiichi Sankyo and AstraZeneca 's Dato-DXd (Datroway; TROP2 ADC) has been granted an...
Oncofocus Team
Jun 30, 20252 min read
bottom of page
.png)